glp 1 and fatty liver disease Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic (NAFLD): A systematic review - Lv - 2020 - Endocrinology, Diabetes & Metabolism Fatty Liver Disease: How GLP-1

GLP-1 Friendly Grocery List (US Letter PDF)

Unlike diabetic ketoacidosis, the diagnosis of euglycemic diabetic ketoacidosisis often overlooked because of the absence of hyperglycemia.

In response to shortages, the FDA allowed use of compounded GLP-1 drugs. What are “compounded drugs? Most prescription medications are approved by the FDA and manufactured by drug companies.Compoundeddrugs are made by licensed pharmacists or physicians who […]

In this review, we summarize the state-of-the-art evidence regarding the epidemiology and pathophysiology of diabetic HFpEF, and the landscape of the novel antidiabetic drugs in the treatment of diabetic HFpEF, as well as discuss the relevant mechanisms, aiming to broaden the understanding of diabetic HFpEF and gain new insight into the treatment of this disease

It does not titrate up

Understanding the Side Effects of GLP-1 Drugs